← Open Payments lookup

APRILE HARRIS: Open Payments

NPI 1831133701 · ELKTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,248 in 46 payments from 19 companies in 2025. Trend: 2023 $788 · 2024 $1,344 · 2025 $1,248

Food & beverage: $1,226Education: $22
CompanyPaymentsAmount
Ardelyx, Inc.5$275
Calliditas Therapeutics US Inc.4$215
Fresenius USA Marketing, Inc.4$105
Amgen Inc.5$94
Travere Therapeutics, Inc.5$71
Otsuka America Pharmaceutical, Inc.3$67
AstraZeneca Pharmaceuticals LP3$54
Otsuka Pharmaceutical Development & Commercialization, Inc.2$51
AKEBIA THERAPEUTICS INC2$43
Novartis Pharmaceuticals Corporation2$41

Products named: TARPEYO, XPHOZAH 30 MG, VELPHORO, TAVNEOS, IBSRELA, JARDIANCE, Vafseo, JYNARQUE.

Industry payments across MD — which companies pay providers there.